Genentech: differenze tra le versioni

Versione delle 09:05, 26 ago 2020

Versione delle 17:52, 28 ago 2020

Riga 11:

|causa chiusura =

|nazione = USA

|sede = [[South San Francisco]], [[California]]

|gruppo = F.Hoffmann-La Roche SA

|controllate =

|persone chiave = * Severin Schwan [[presidente]] Genentech e [[amministratore delegato|CEO]] di Hoffmann-La Roche

Riga 46:

== Collegamenti esterni ==

* {{collegamenti esterni}}

*http://bancroft.berkeley.edu/ROHO/projects/biosci/oh_list.html

* {{cita web|http://www.gene.com/|Genentech official website}}

* {{Cita web | titolo=Corporate Chronology| editore=Genentech Inc. | url=http://www.gene.com/gene/about/corporate/history/timeline.html | accesso=30 maggio 2005}}

* [https://www.nytimes.com/2006/02/15/business/15drug.html?ex=1297659600&en=62aabaec5acffa8c&ei=5090&partner=rssuserland&emc=rss A Cancer Drug Shows Promise, at a Price That Many Can't Pay] ''[[New York Times]]'', February 15, 2006, Alex Berenson

*[https://web.archive.org/web/20070927033418/http://usfmbapodcast.com/2007/01/10/11-genentech-net-impact-tour/ Presentation by Genentech employees about Sustainable Business] January 10, 2007

{{Controllo di autorità}}